Harmony Biosciences Q2 EPS $1.28 Beats $0.94 Estimate, Sales $261.300M Beat $248.406M Estimate
Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $0.94 by 36.17 percent. This is a 39.13 percent increase over earnings of $0.92 per share
Harmony Biosciences made more money than experts predicted this quarter—both the profits per share and total sales came in stronger. When a company beats expectations like this, it can signal the business is running well and people might feel more confident about it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.